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Activation of apoptosis by Apo-2 ligand is independent of FADD but
blocked by CrmA
Scot A. Marsters*†, Robert M. Pitti*†, Christopher J. Donahue‡, Siegfried Ruppert§,
Kenneth D. Bauer‡ and Avi Ashkenazi*
A new member of the tumor necrosis factor (TNF)
cytokine family, designated Apo-2 ligand (Apo-2L) [1] or
TRAIL [2], has been shown recently to induce apoptosis
in various tumor cell lines; however, its biological role is
unknown. Here, we show that Apo-2L activated
apoptosis in T-cell-enriched cultures of peripheral blood
lymphocytes stimulated by interleukin-2 (IL-2), but not in
unstimulated cells. This finding suggests that, like
Fas/Apo-1 ligand and TNF [3–5], Apo-2L may play a role
in regulating post-stimulation apoptosis of mature
lymphocytes. Studies on the mechanism of Apo-2L
action demonstrated marked membrane blebbing, a
hallmark of apoptosis, within a few minutes of the
addition of Apo-2L to tumor cells. Ectopic expression of
a dominant negative mutant of FADD, a cytoplasmic
protein that mediates death signalling by Fas/Apo-1 and
by TNF receptor type 1 (TNFR1) [6–9], inhibited the
induction of apoptosis by anti-Fas/Apo-1 antibody, but
had little effect on Apo-2L function. In contrast,
expression of CrmA, a cowpox virus-derived inhibitor of
the Ced-3-like proteases ICE [10] and CPP32/Yama
[11,12], blocked the induction of apoptosis by either
Apo-2L or anti-Fas/Apo-1 antibody. These results
suggest that Apo-2L activates a rapid, FADD-
independent pathway to trigger a cell-death programme
that requires the function of cysteine proteases such as
ICE or CPP32/Yama.
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Results and discussion 
To begin to elucidate the biological role of Apo-2L, we
investigated whether soluble Apo-2L [1] induced apopto-
sis in T-cell-enriched cultures of human peripheral blood
lymphocytes. We observed no increase above background
levels of apoptosis in resting cells; however, stimulation for
3 days by IL-2, a cytokine that predisposes mature T cells
to antigen-induced apoptosis [13], rendered a significant
fraction of the cells sensitive to Apo-2L-induced death
(Fig. 1). In five independent experiments, Apo-2L caused
Figure 1
Apo-2L induces apoptosis in T-cell-enriched cultures of peripheral blood
cells stimulated by IL-2. The carboxy-terminal extracellular region of
human Apo-2L (amino-acid residues 114–281) was expressed with an
amino-terminal His10 tag by baculovirus transduction into SF9 cells and
purified by Ni2+ affinity chromatography, as described [1]; a control was
generated by processing identically SF9 cells infected with baculovirus
lacking the Apo-2L cDNA. Peripheral blood mononuclear cells were
isolated from pooled blood of 3 human donors by Ficoll density-gradient
centrifugation with Lymphocyte Separation Medium (Organon Teknika).
T-cell enrichment was performed by removal of B cells through surface
immunoglobulin (Ig) binding to an anti-Ig column and removal of
monocytes by binding to an Ig column (R&D Systems). The T cells were
cultured for 3 days in absence (a) or presence (b) of 100 U ml–1 human
IL-2 (Genzyme). Of the cells in these cultures, ~90 % were CD3-positive,
representing T cells, and~5 % were CD3-negative/CD56-positive,
representing NK cells. The cultures were treated by control or by purified
soluble Apo-2L (1 mg ml–1) for 24 h. T cells were gated by staining with a
mixture of phycoerythrin (PE)-conjugated anti-CD4 and anti-CD8
antibodies (Jackson Immunoresearch). Apoptotic T cells were identified
by staining with fluoresceinthiocyanate (FITC)-conjugated annexin V
(Brand Applications), which binds to exposed phosphatidylserine on the
surface of apoptotic cells, and by staining with the dye 7-
aminoactinomycin D (7AAD), which penetrates cells that have lost
membrane integrity [22,23]. Annexin V-positive/7AAD-negative cells are
in early stages of apoptosis and double-positive cells are in late
apoptosis, whereas Annexin V-negative/7AAD-positive cells are necrotic.
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a marked increase in apoptosis of IL-2-treated cells: the
mean induction was 2.5-fold as compared with IL-2-treated
controls, and 5-fold as compared with resting cells (Table
1). Consistent with previous reports [14,15], a 3-day expo-
sure to IL-2 was not sufficient to confer significant sensitiv-
ity on the cells to induction of apoptosis by agonistic
anti-Fas/Apo-1 antibody (Table 1).
To gain insight into the mechanism of apoptosis induction
by Apo-2L, we investigated some of the intracellular
events that occur after exposure to Apo-2L. Internucleoso-
mal DNA fragmentation, a process characteristic of apop-
totic cells, is detectable within 2 hours of soluble Apo-2L
treatment of tumor cell lines [1]. Another hallmark of
apoptosis is the dramatic change in plasma membrane
architecture known as membrane blebbing. Addition of
Apo-2L to 9D cells induced marked membrane-blebbing
activity within 6–9 minutes (Fig. 2), indicating a rapid
apoptotic signalling mechanism. Agonistic anti-Fas/Apo-1
antibody also induced membrane blebbing in 9D cells
within a similar period of time (data not shown).
We have shown previously that Apo-2L acts indepen-
dently of Fas/Apo-1, TNFR1 or TNFR2 [1]. Recent work
has identified FADD/MORT-1 as a death domain-con-
taining protein that interacts with the death domain of
Fas/Apo-1 to signal apoptosis [6,7]. FADD appears also to
play a key role in TNF-induced apoptosis, by interacting
indirectly with TNFR1 via another death domain-contain-
ing protein, TRADD [8,9]. To test whether FADD is
important for Apo-2L function, we transfected HeLa-S3
cells (clone H7; [16]) transiently with a dominant-negative
mutant of FADD (residues 80–205) [8]. Expression of this
FADD mutant inhibited substantially the induction of
apoptosis by agonistic anti-Fas/Apo-1 antibody, but had
little effect on Apo-2L-induced death (Fig. 3). Thus,
FADD does not appear to play an obligatory role in death
signalling by Apo-2L.
Programmed cell death involves the activity of members
of a family of cysteine proteases related to the Caenorhab-
ditis elegans cell death gene ced-3 and to the mammalian
IL-1-converting enzyme (ICE) [17]. The activity of two of
these proteases, ICE and CPP32/Yama, can be inhibited
by the product of the cowpox virus gene crmA [10,12].
Recent studies show that CrmA inhibits TNF and
Fas/Apo-1-induced cell death [18–20]. Ectopic expression
of CrmA in HeLa-S3 cells inhibited the induction of apop-
tosis by Apo-2L, as well as by anti-Fas/Apo-1 antibody
(Fig. 3). This finding indicates that the activity of cysteine
proteases such as ICE and/or CPP32/Yama is required for
Apo-2L-induced cell death.
In conclusion, our results show that Apo-2L activates apop-
tosis in T-cell-enriched cultures of peripheral blood lym-
phocytes after stimulation by IL-2. Because Fas/Apo-1L
and TNF also have been shown to induce apoptosis in
stimulated T cells [3–5], our observation suggests a greater
level of complexity than was previously recognised in the
regulation of the mature lymphocyte repertoire. It is
notable in this context that deletion of the IL-2 receptor a
chain gene in mice leads to a marked increase in the size of
the peripheral lymphoid compartment, suggesting that
IL-2 regulates not only proliferation but also apoptosis of
lymphocytes [21]. Thus, perhaps one mechanism by which
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Table 1
Induction of apoptosis by Apo-2L in T-cell-enriched cultures of
peripheral blood lymphocytes treated by IL-2.
% Apoptotic cells
Pretreatment Control Apo-2L Control Anti-Fas/
Apo-1
None                      6.3 ± 0.6 8.2 ± 0.8 5.4 ± 0.6 7.4 ± 1.3
IL-2                     13.7 ± 1.2 34.5 ± 4.8* 11.7 ± 2.5 18.1 ± 2.4
Depicted are means ± SE of 5 experiments. In each experiment, blood
from 3 donors was pooled and T-cell-enriched cultures were prepared as
in Figure 1. Cultures were treated with IL-2 (100 U ml–1) for 3 days and
then treated with 1 µg ml–1 soluble Apo-2L [1] or agonistic anti-Fas/Apo-
1 monoclonal antibody CH-11 (Medical Biological Laboratories) for 24 h.
Apoptosis was analysed in 50 000 cells per data point, as in Figure 1.
Statistical analysis was by two-tailed Student t test; *p < 0.02, as
compared with the respective control.
Figure 2
Rapid induction of membrane blebbing by Apo-2L. 9D cells, shown
previously to undergo apoptosis in response to Apo-2L [1], were
placed under a microscope in a chamber that maintains normal culture
conditions (5 % CO2, 37 °C in a humidified chamber) and recorded by
time-lapse video microscopy. The figure depicts four digitized images
taken immediately before (a), or approximately 6 min (b), 9 min (c) and
16 min (d) after addition of Apo-2L (1 mg ml–1). Notice the membrane-
blebbing activity in the group of cells in the centre of the field (b), and
in the centre and lower parts of the field (c), or throughout the field (d).
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IL-2 regulates the mature lymphocyte compartment is by
inducing sensitivity to Apo-2L-mediated cell death.
Our studies in cell lines show that Apo-2L activates apop-
tosis rapidly, within a time frame that is similar to death
signalling by Fas/Apo-1L but much faster than TNF-
induced apoptosis [3-5]. The observation that Apo-2L
triggers apoptosis independently of FADD, which is used
by both Fas/Apo-1 and TNFR1, suggests the potential
involvement of different signal-transducing elements in
Apo-2L function. Finally, our data indicate an essential
role for ICE and/or CPP32/Yama in Apo-2L-induced
apoptosis. Thus, TNF, Fas/Apo-1L and Apo-2L may use
different membrane-proximal signalling mechanisms to
activate a common cell-death programme.
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Figure 3
Characterization of death-signaling by Apo-2L. HeLa-S3 cells (clone
H7; [16]) were transfected by electroporation with the following
plasmids: pRK5.CD4 (5 mg) plus pRK5 (20 mg) (control), pRK5.CD4
(5 mg) plus pRK5 encoding a dominant-negative FADD(80–205)
(FADD-DN) [8] (20 mg), or pRK5.CD4 (5 mg) plus pRK5.CrmA
(20 mg). 24 h after transfection, the cells were treated with Apo-2L or
with anti-Fas/Apo-1 antibody CH-11 for an additional 20 h.
Transfected cells were gated based upon the presence of surface
CD4 measured with PE-conjugated anti-CD4 antibody, and analyzed
for apoptosis as in Figure 1.
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